Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Clinical trial NCT06005428 · TERMINATED
Trial details
- NCT number
- NCT06005428
- Sponsor
- Cardurion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2025-05-31
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.